based on a number of assumptions about oncogene size , frequency , biological integrity , and in vitro as well as in vivo transformation efficiency , estimates are made of the risk that the residual cellular dna ( rcdna ) contaminant in a biological product will cause a neoplastic transformation event .
C0029016
oncogene
C0007621
neoplastic transformation